Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
NEUPOGEN
(https://neupogen.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Daily White Blood Cell Booster | Neupogen® (filgrastim) (https://neupogen.com)
Daily White Blood Cell Booster | Neupogen® (filgrastim)
If you are on a strong chemotherapy and at risk for developing febrile neutropenia, find out more about Neupogen® (filgrastim). See Important Safety Info.
NAV_HEADER_HEADING_REPEATED_BODY What is Neupogen® (filgrastim)? | G-CSF Injection (https://neupogen.com/about/)
What is Neupogen® (filgrastim)? | G-CSF Injection
Learn more about Neupogen® (filgrastim) including how it works, clinical study results, dosing and administration details and approved usage information.
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Neupogen® (filgrastim) Support and Resource Center (https://neupogen.com/resources-support/)
Neupogen® (filgrastim) Support and Resource Center
Learn about organizations that help in the fight against cancer and questions to ask your doctor when talking about infection risk and Neupogen® (filgrastim)
NAV_HEADER_HEADING_REPEATED_BODY Helping Reduce Infection Risk From Strong Chemotherapy (https://neupogen.com/infection-risk/)
Helping Reduce Infection Risk From Strong Chemotherapy
Find out how chemotherapy affects your body as well as details on how Neupogen® (filgrastim) may be able to help reduce the risk of infection during chemo.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://neupogen.com) Daily White Blood Cell Booster | Neupogen® (filgrastim)
See Less [H3] [H2] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN®. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN®: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information. See More [H5] [H2] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information.
SUB-PAGE (https://neupogen.com/about/) What is Neupogen® (filgrastim)? | G-CSF Injection
[H2] What is NEUPOGEN® used for? [H3] NEUPOGEN® is approved for several uses to help boost the production of white blood cells [H4] Patients with Cancer Receiving Strong Chemotherapy NEUPOGEN® is a prescription medicine used to help the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid) who receive anti-cancer medicines (chemotherapy) that can cause fever and a low blood cell count. [H4] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information. USA-003-80219 [H4] Patients with Acute Myeloid Leukemia (AML) Receiving Chemotherapy NEUPOGEN® is a prescription medicine used to help the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid) who receive anti-cancer medicines (chemotherapy) that can cause fever and a low blood cell count. [H4] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information. USA-003-80219 [H4] Patients with Cancer Undergoing Bone Marrow Transplantation (BMT) NEUPOGEN® is a prescription medicine used to help the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid) who receive anti-cancer medicines (chemotherapy) that can cause fever and a low blood cell count. [H4] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-
SUB-PAGE (https://neupogen.com/resources-support/) Neupogen® (filgrastim) Support and Resource Center
[H1] Glossary Bacteria — Among the smallest forms of life. Bacteria are the most common causes of infections in people with cancer. Some examples of bacterial infection include food poisoning, pneumonia, and strep throat.Chemotherapy — The use of drugs to destroy cancer cells. A person on chemotherapy may take one drug or a combination of drugs. These drugs are often given by vein using intravenous (IV) infusion. Some can be taken by mouth or given as a shot.Co-pay — A flat fee for specified medical services required by some insurers. For example, your insurance provider may require you to pay a $10 co-pay for a doctor visit or a $50 co-pay for a hospital stay.Cycle — A period of chemotherapy treatment followed by a period of rest. For example, you may receive chemotherapy over 1 week followed by a week without treatment. These 2 weeks are one cycle of chemotherapy.Febrile neutropenia — A condition marked by fever and a lower than normal number of neutrophils in the blood. A neutrophil is a type of white blood cell that helps fight infection. Having too few neutrophils increases that risk of infection.Infection — An invasion of microorganisms such as bacteria or viruses that have the ability to multiply and cause disease.Intravenous (IV) infusion — The delivery of medicine directly into a vein.Neutropenia — A lower-than-normal number of neutrophils (infection-fighting white blood cells) in the blood. It is a common side effect of some chemotherapy treatments. Doctors check the number of neutrophils when they measure the white blood cell count, to monitor the risk of infection.Neutrophil — The most common type of white blood cell. Neutrophils help the body fight infection. A low white blood cell count usually indicates that the neutrophil count is low. It is easier to get an infection and harder to recover from an infection when the number of neutrophils in the bloodstream is low.Placebo — A dummy treatment used in some clinical trials. In these studies, a group of patients who are given a placebo treatment are compared to another group of patients who are given the actual treatment. The difference in results between the actual treatment group and the placebo group is considered the result of giving the medicine.Side effect — A secondary and usually undesired action or effect of a drug or treatment. For example, common side effects of chemotherapy include fatigue, nausea, vomiting, and hair loss.Subcutaneous injection — A shot given in the layer of fatty tissue just under the skin.White blood cell — A white blood cell is one of the three main types of blood cells. They are produced in the bone marrow and released into the blood. White blood cells are responsible for fighting infection. There are several kinds of white blood cells, including monocytes, lymphocytes, neutrophils, and macrophages.
SUB-PAGE (https://neupogen.com/infection-risk/) Helping Reduce Infection Risk From Strong Chemotherapy
See Less [H3] [H2] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN®. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN®: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information. See More [H5] [H2] Important Safety Information Do not take NEUPOGEN® if you have had a serious allergic reaction to human G-CSFs such as (filgrastim) or (pegfilgrastim) products. Before you take NEUPOGEN®, tell your healthcare provider all about your medical conditions, including if you: have a sickle cell disorder. have kidney problems. are receiving radiation therapy. are allergic to latex. The needle cap on the prefilled syringe contains dry natural rubber (derived from latex). You should not give NEUPOGEN® using the prefilled syringe if you have latex allergies. Ask your healthcare provider about using the vial if you have latex allergies. are pregnant, or plan to become pregnant. It is not known if NEUPOGEN® will harm your unborn baby. are breastfeeding, or plan to breastfeed. It is not known if NEUPOGEN® passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive NEUPOGEN®? NEUPOGEN® injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If NEUPOGEN® is given at home, see the detailed "Instructions for Use" that comes with your NEUPOGEN® for information on how to prepare and inject a dose of NEUPOGEN®. You and your caregiver should be shown how to prepare and inject NEUPOGEN® before you use it, by your healthcare provider. Your healthcare provider will tell you how much NEUPOGEN® to inject and when to inject it. Do not change your dose or stop NEUPOGEN® unless your healthcare provider tells you to. If you are receiving NEUPOGEN® because you are also receiving chemotherapy, your dose of NEUPOGEN® should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your NEUPOGEN dose. If you are receiving NEUPOGEN because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with NEUPOGEN to check your white blood cell count. If you miss a dose of NEUPOGEN, talk to your healthcare provider about when you should be given your next dose. What are possible side effects of NEUPOGEN®? NEUPOGEN may cause serious side effects, including: Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or left shoulder. A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing. Serious allergic reactions. NEUPOGEN® can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using NEUPOGEN®, and call your healthcare provider or get emergency help right away. Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive NEUPOGEN®. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing. Kidney injury (glomerulonephritis). NEUPOGEN® can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms: swelling of your face and ankles blood in your urine or dark colored urine you urinate less than usual Capillary Leak Syndrome. NEUPOGEN® can cause fluid to leak from blood vessels into your body's tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms: swelling or puffiness and are urinating less than usual trouble breathing swelling of your stomach-area and feeling of fullness dizziness or feeling faint a general feeling of tiredness Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). NEUPOGEN® may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia). If you have breast cancer or lung cancer, when NEUPOGEN® is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML. Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop any of these symptoms during treatment with NEUPOGEN®. Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with NEUPOGEN®. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot. Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with NEUPOGEN®. Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin. Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received NEUPOGEN. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms. The most common side effects experienced in patients receiving NEUPOGEN: Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash Patients who are having their own blood cells collected: bone pain, fever, and headache Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss These are not all the possible side effect of NEUPOGEN®. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-332-1088. Please see the NEUPOGEN® Patient Information for additional information.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 0 |
| /about/ | 1 | 0 |
| /resources-support/ | 1 | 0 |
| /infection-risk/ | 1 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
NEUPOGEN has 11.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: NEUPOGEN (neupogen.com)
The site is a highly compliant but technically dated pharmaceutical portal. While it avoids the typical ‘disruptive’ fluff of startups, it creates BS through clinical vagueness (‘natural defenses’) and a total lack of modern technical trust signals like structured data schema. It is more a regulatory brochure than a proof-driven clinical resource.
Immediately implement Drug and Organization schema to link the website to official FDA and ClinicalTrials.gov databases. Replace the consumer-facing fluff in the H1 heading (‘natural defenses’) with the specific clinical outcome, such as ‘Reduces the Incidence of Febrile Neutropenia.’ Add a ‘Clinical Evidence’ section that provides direct, cited data from pivotal trials instead of general ‘Study Results’ summaries. Eliminate the singular, unverified review count to avoid the trust theatre penalty.
The website perfectly aligns with the Pharma & Biotech industry, characterized by dense regulatory disclosures and technical clinical terminology. The content focuses entirely on filgrastim, a G-CSF biological product, used in chemotherapy contexts.
“The score of 29 is primarily driven by technical identity gaps (8 points in Identity and Authority) and a trust theatre penalty (9 points) resulting from the lack of external proof paths and anomalous review counts. Information Density (9 points) reflects the high repetition of the value prop and the use of soft marketing language in headings despite the high-substance ISI body text.”
This training module utilizes a snapshot of public data from NEUPOGEN, captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to NEUPOGEN: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://neupogen.com to view the most current version of its content and learn from the source what this company is about and what it offers.